JUN 23, 2017 8:23 PM PDT

Delivering A New HIV Vaccine

WRITTEN BY: Kara Marker

Creating a successful vaccine for HIV has so far been unsuccessful, but now scientists are zeroing in on two important factors for perfecting the vaccine: timing and mode of delivery.

The vaccine candidates used in the study mimic the trimeric envelope protein spikes on the surface of HIV. Rendering of HIV with envelope protein trimers clearly visible on the virus surface. Credit: La Jolla Institute for Allergy and Immunology

The potential HIV vaccine is based on neutralizing antibodies, which attach to viruses and prevent them from promoting infection. However, in the past neutralizing antibodies have been “notoriously difficult” to create in the context of targeting HIV. From the La Jolla Institute for Allergy and Immunology, researchers tested the efficacy of an optimized vaccine in non-human primates, a traditional model for studying HIV. However, the initial vaccine wasn’t successful at first.

"The animals' immune responses, although the right kind, weren't very robust and a few didn't respond at all," explained Colin Havenar-Daughton, PhD. "That caused significant concern that the immunogen wouldn't consistently trigger an effective immune response in all individuals in a human clinical trial."

They improved upon the vaccine, using subcutaneous delivery - under the skin like insulin and morphine injections. Additionally, they increased the time intervals between immunizations, ensuring a slow and steady delivery. This makes the vaccine’s effect stronger, activating the neutralizing antibodies.

"Depending on how we gave the vaccine, there was a bigger difference due to immunization route than we would have predicted," explained co-lead author Matthias Pauthner. "We can help translate what we know now into the clinic."

HIV in 2017

HIV is now relatively considered to be a “chronic, manageable disease” thanks to antiretroviral drugs that treat AIDS. Although, accessibility to these drugs isn’t guaranteed; only half of people living with HIV have access to treatment, and new people are contracting the disease every day. The new

"The vaccine candidates we worked with here are probably the most promising prototypes out there, and one will go into people in 2018," said Professor Dennis R. Burton, PhD.

The present study was published in the journal Immunity.

 

Source: La Jolla Institute for Allergy and Immunology, Healthline

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUL 22, 2019
Immunology
JUL 22, 2019
How to Kill Superbugs
https://www.technologynetworks.com/immunology/news/enhancing-the-infection-fighting-potential-of-natural-products-321553...
SEP 25, 2019
Immunology
SEP 25, 2019
Your Immune Response Varies from AM to PM
“My biological clock is ticking.” We’ve heard people say this phrase - maybe even said it ourselves - but what do we mean exactly? Often...
OCT 16, 2019
Health & Medicine
OCT 16, 2019
Study Links High Birth Weight to Risk of Allergies
Researchers from the University of Adelaide, Australia have linked the risk of developing childhood food allergies and eczema to heavier birth weight. The...
NOV 17, 2019
Cell & Molecular Biology
NOV 17, 2019
Scientists Reveal a Link Between Brain Fog and Inflammation
When people get sick, they often also feel tired, which can be as troublesome as their disease....
DEC 20, 2019
Neuroscience
DEC 20, 2019
Does Having Herpes Increase Your Risk for Alzheimer's?
Around 44 million people around the world have Alzheimer’s disease, a progressive form of dementia that leads to memory loss and a decline in cogniti...
FEB 21, 2020
Drug Discovery & Development
FEB 21, 2020
New Antibiotics Found Using AI Technology
Using AI, researchers at MIT have found a powerful new antibiotic capable of killing some of the most dangerous drug-resistant bacteria known to man. ...
Loading Comments...